Strategic Financial Services’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-33
Closed -$1K 130
2022
Q3
$1K Hold
33
﹤0.01% 126
2022
Q2
$2K Hold
33
﹤0.01% 129
2022
Q1
$5K Hold
33
﹤0.01% 138
2021
Q4
$6K Hold
33
﹤0.01% 133
2021
Q3
$17K Sell
33
-600
-95% -$278K ﹤0.01% 128
2021
Q2
$317K Hold
633
0.03% 115
2021
Q1
$321K Hold
633
0.03% 113
2020
Q4
$302K Buy
633
+66
+12% +$21.7K 0.03% 117
2020
Q3
$163K Buy
567
+100
+21% +$24.8K 0.02% 123
2020
Q2
$89K Hold
467
0.01% 124
2020
Q1
$58K Hold
467
0.01% 120
2019
Q4
$82K Hold
467
0.01% 134
2019
Q3
$70K Hold
467
0.01% 132
2019
Q2
$54K Hold
467
0.01% 133
2019
Q1
$79K Hold
467
0.01% 131
2018
Q4
$55K Buy
+467
New +$71.7K 0.01% 128

Other funds holding AMPE

Strategic Financial Services's AMPE Position: Q4 2022 in Review

Strategic Financial Services sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 33 shares — an estimated $1K sold.

Strategic Financial Services first reported a position in AMPE in Q4 2018 and held it in 16 quarters. The position peaked at $321K in Q1 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Strategic Financial Services reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • Strategic Financial Services sold 33 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $1K.
  • Strategic Financial Services first reported a position in Ampio Pharmaceuticals Inc. in Q4 2018 and held it in 16 quarters.
  • Strategic Financial Services's Ampio Pharmaceuticals Inc. position peaked at $321K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Strategic Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.